Overexpression of alpha-synuclein at non-toxic levels increases dopaminergic cell death induced by copper exposure via modulation of protein degradation pathways by Anandhan, Annadurai et al.
University of Nebraska - Lincoln
DigitalCommons@University of Nebraska - Lincoln
Biochemistry -- Faculty Publications Biochemistry, Department of
2015
Overexpression of alpha-synuclein at non-toxic
levels increases dopaminergic cell death induced by
copper exposure via modulation of protein
degradation pathways
Annadurai Anandhan
University of Nebraska-Lincoln
Humberto Rodriguez-Rocha
University of Nebraska-Lincoln
Iryna Bohovych
University of Nebraska-Lincoln, ibohovych2@unl.edu
Amy M. Griggs
Purdue University
Laura Zavala-Flores
University of Nebraska-Lincoln
See next page for additional authorsFollow this and additional works at: https://digitalcommons.unl.edu/biochemfacpub
Part of the Biochemistry Commons, Biotechnology Commons, and the Other Biochemistry,
Biophysics, and Structural Biology Commons
This Article is brought to you for free and open access by the Biochemistry, Department of at DigitalCommons@University of Nebraska - Lincoln. It
has been accepted for inclusion in Biochemistry -- Faculty Publications by an authorized administrator of DigitalCommons@University of Nebraska -
Lincoln.
Anandhan, Annadurai; Rodriguez-Rocha, Humberto; Bohovych, Iryna; Griggs, Amy M.; Zavala-Flores, Laura; Reyes-Reyes, Elsa M.;
Seravalli, Javier; Stanciu, Lia A.; Lee, Jaekwon; Rochet, Jean-Christophe; Khalimonchuk, Oleh; and Franco, Rodrigo, "Overexpression
of alpha-synuclein at non-toxic levels increases dopaminergic cell death induced by copper exposure via modulation of protein
degradation pathways" (2015). Biochemistry -- Faculty Publications. 232.
https://digitalcommons.unl.edu/biochemfacpub/232
Authors
Annadurai Anandhan, Humberto Rodriguez-Rocha, Iryna Bohovych, Amy M. Griggs, Laura Zavala-Flores,
Elsa M. Reyes-Reyes, Javier Seravalli, Lia A. Stanciu, Jaekwon Lee, Jean-Christophe Rochet, Oleh
Khalimonchuk, and Rodrigo Franco
This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/biochemfacpub/232
Overexpression of alpha-synuclein at non-toxic levels increases 
dopaminergic cell death induced by copper exposure via 
modulation of protein degradation pathways
Annadurai Anandhana,b, Humberto Rodriguez-Rochaa,b,1, Iryna Bohovychc, Amy M. 
Griggsd, Laura Zavala-Floresa,b,1, Elsa M. Reyes-Reyesf, Javier Seravallia,c, Lia A. Stanciue, 
Jaekwon Leea,c, Jean-Christophe Rochetd, Oleh Khalimonchuka,c, and Rodrigo Francoa,b,*
aRedox Biology Center, University of Nebraska-Lincoln, Lincoln, NE, USA
bSchool of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, 
Lincoln, NE, USA
cDepartment of Biochemistry, University of Nebraska-Lincoln, Lincoln, NE, USA
dDepartment of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West 
Lafayette, IN, USA
eWeldon School of Biomedical Engineering and School of Materials Engineering, Purdue 
University, West Lafayette, IN, USA
fCollege of Medicine, The University of Arizona, Tucson, AZ, USA
Abstract
Gene multiplications or point mutations in alpha (α)-synuclein are associated with familial and 
sporadic Parkinson’s disease (PD). An increase in copper (Cu) levels has been reported in the 
cerebrospinal fluid and blood of PD patients, while occupational exposure to Cu has been 
suggested to augment the risk to develop PD. We aimed to elucidate the mechanisms by which α-
synuclein and Cu regulate dopaminergic cell death. Short-term overexpression of WT or A53T α-
synuclein had no toxic effect in human dopaminergic cells and primary midbrain cultures, but it 
exerted a synergistic effect on Cu-induced cell death. Cell death induced by Cu was potentiated by 
overexpression of the Cu transporter protein 1 (Ctr1) and depletion of intracellular glutathione 
(GSH) indicating that the toxic effects of Cu are linked to alterations in its intracellular 
homeostasis. Using the redox sensor roGFP, we demonstrated that Cu-induced oxidative stress 
was primarily localized in the cytosol and not in the mitochondria. However, α-synuclein 
overexpression had no effect on Cu-induced oxidative stress. WT or A53T α-synuclein 
overexpression exacerbated Cu toxicity in dopaminergic cells and yeast in the absence of α-
synuclein aggregation. Cu increased autophagic flux and protein ubiquitination. Impairment of 
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autophagy by overexpression of a dominant negative Atg5 form or inhibition of the ubiquitin/
proteasome system (UPS) with MG132 enhanced Cu-induced cell death. However, only inhibition 
of the UPS stimulated the synergistic toxic effects of Cu and α-synuclein overexpression. Our 
results demonstrate that α-synuclein stimulates Cu toxicity in dopaminergic cells independent 
from its aggregation via modulation of protein degradation pathways.
Keywords
α-Synuclein; A53T; Autophagy; Proteasome; Ubiquitination; Oxidative stress; AMPK; Copper 
and Parkinson’s disease
Introduction
The progressive neurodegeneration in Parkinson’s disease (PD) is characterized by the loss 
of dopaminergic neurons in the substantia nigra, and the presence of the fibrillar cytoplasmic 
aggregates of α-synuclein. Multiplication and mutations in α-synuclein (SNCA/PARK1) 
(Chartier-Harlin et al., 2004; Polymeropoulos et al., 1997) and its abnormal aggregation are 
implicated in the etiology of familial or sporadic PD, as well as in other α-synucleinopathies 
(Galvin et al., 2001; Stefanis, 2012). A53T mutation is the most frequent mutation with a 
penetrance of 85%, while duplications have only reduced penetrance suggesting that 
additional factors might contribute to disease progression. Gene dosage (number of SNCA 
copies) has been associated with an earlier onset, more severe phenotype, and faster disease 
progression (Klein and Westenberger, 2012; Rochet et al., 2012). Conformational changes in 
α-synuclein including oligomerization and fibrillogenesis are also associated with PD. α-
synuclein aggregation is modulated by various mechanisms including phosphorylation, C-
terminal truncation, interactions with metals or redox reactions (Breydo et al., 2012; 
Stefanis, 2012). However, the pathogenicity of these conformational changes is unclear as 
some studies suggest that mature fibrils might sequester toxic protofibrillar intermediates, 
and that aggregation of α-synuclein is required for its detoxification (Klucken et al., 2012). 
A variety of transgenic animal models overexpressing either WT or mutant α-synuclein 
have been established. Nevertheless, dopaminergic cell loss is poorly observed in most of 
these transgenic mouse models (Horowitz and Greenamyre, 2010). These observations 
suggest that other factors, including aging or environmental exposures might contribute to 
PD associated with alterations in α-synuclein (Cannon and Greenamyre, 2013; Horowitz 
and Greenamyre, 2010; Stefanis, 2012).
Only 10% of people with PD have a family history of this disorder (Klein and 
Westenberger, 2012). Most of PD occurs in a sporadic (idiopathic) form, without a defined 
genetic basis. Thus, it is considered that PD arises from the convergence of genetic 
susceptibility, environmental factors, and aging (Horowitz and Greenamyre, 2010; Vance et 
al., 2010). Epidemiological evidence suggests an involvement of heavy metals in the 
etiology of PD (Santner and Uversky, 2010). Dysregulation of intracellular metal 
homeostasis has been suggested as a contributor to PD progression (Ayton et al., 2012). An 
increase in copper (Cu) levels has been reported in the cerebrospinal fluid and blood of PD 
patients (Hozumi et al., 2011; Pall et al., 1987), while occupational exposure to Cu augments 
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the risk to develop PD (Gorell et al., 1997, 1999; Rybicki et al., 1993; Santner and Uversky, 
2010). In contrast, other studies have reported a decrease or no change in Cu levels in the 
serum of PD patients or in the substantia nigra of post-mortem PD brains (Dexter et al., 
1989; Jimenez-Jimenez et al., 1992; Mariani et al., 2013).
Cu is an essential metal ion in the central nervous system. As a transition metal, Cu mediates 
oxidation-reduction reactions and participates in the generation of reactive oxygen species 
(ROS) and oxidative damage. Thus, a number of Cu-binding proteins and transporters have 
evolved to facilitate Cu-dependent enzymatic processes, maintain Cu homeostasis, and 
minimize its detrimental effects (Kim et al., 2008). An unbalanced intracellular Cu 
homeostasis induces profound defects in neurological function. Human genetic disorders 
involving dysfunction of Cu-transporting ATPases, such as Menke’s and Wilson’s disease, 
have demonstrated the importance of Cu homeostasis in brain function. For example, the Cu 
overload in Wilson’s disease leads to oxidative stress and progressive neurodegeneration 
that develops in parkinsonism (Gaier et al., 2013).
Previous studies have aimed to understand the mechanism by which Cu regulates α-
synuclein aggregation and toxicity. In this study, we demonstrated that non-toxic α-
synuclein overexpression can increase dopaminergic cell death induced by Cu, independent 
from oxidative stress or α-synuclein aggregation. The synergistic toxicity induced by Cu and 
α-synuclein overexpression was found to be linked to the regulation of protein degradation 
pathways, particularly the ubiquitin proteasome system (UPS). These results demonstrate 
that α-synuclein can stimulate Cu toxicity independent from its aggregation.
Materials and methods
Cell culture and reagents
The dopaminergic properties of the neuroblastoma cell line SK-N-SH and their cell culture 
have been detailed before (Garcia-Garcia et al., 2013). Wild type (WT), double knockout 
AMPK (DKO-AMPK−/−) and Ulk1 knockout (Ulk1−/−) mouse embryonic fibroblasts 
(MEFs) were kindly provided by Dr. Mondira Kundu (St. Jude Children’s Research 
Hospital) and Dr. Benoit Viollet (Institut Cochin INSERM) (J. Kim et al., 2011). MEFs 
were cultured in Dulbecco’s Modified Eagle: Nutrient Mixture F-12 (DMEM/F-12) media 
supplemented with 10% [v/v] fetal bovine serum (FBS), penicillin (200 U/ml), streptomycin 
(200 μg/ml), 2 mM L-glutamine, and 200 μM β-mercaptoethanol. Cell culture reagents were 
obtained from Thermo Scientific/Hyclone or Life Technologies/GIBCO. L-buthionine-
sulfoximide (B2515) and Chloroquine (C6628) were obtained from Sigma/Aldrich. CuCl2, 
was from Thermo/Fisher Scientific. z-VAD-FMK (carbobenzoxy-valyl-alanyl-aspartyl-[O-
methyl]-fluoromethylketone, 219007) and Ac-DMQD-CHO (235421) were from EMD 
Millipore. MG132 (carbobenzoxy-L-leucyl-L-leucyl-L-leucinal, Z-LLL-CHO) was obtained 
from Cayman Chemical. When inhibitors were used, control samples contained equal 
volume or concentration of vehicle (DMSO), which never exceeded 1% (v/v). All other 
reagents were obtained from Sigma/Aldrich, Thermo/Fisher Scientific or Acros Organics.
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Intracellular Cu analysis by inductively coupled plasma mass spectrometry (ICP-MS)
Cells with and without CuCl2 supplementation were harvested and washed twice in TBS + 
EDTA (10 mM) to remove Cu that had not been incorporated by cells. Cell pellets were 
dissolved in 20% [v/v] HNO3 overnight at room temperature. Cu levels were measured in an 
ICP-MS 7500cs (Agilent) coupled to an autosampler (Elemental Scientific). The instrument 
was operated in collision/reaction mode (He 3.5 ml/min) for the elimination of polyatomic 
species. The system used 2% [v/v] HNO3 as rinse and carrier fluid. 50 ppb gallium (Ga) was 
added to each sample as an internal standard. The concentrations of Cu were calculated from 
an external calibration curve yielding linear fits with correlation coefficients equal or better 
than 0.998. The total acquisition time was 65 s per sample and each isotope was read 3 times 
with dwell times of 0.1 s in triplicate. The results were normalized to protein concentration.
Recombinant adenoviral vectors
Replication-deficient recombinant adenoviruses (Ad5CMV) encoding WT and mutant A53T 
α-synuclein have been described previously (Liu et al., 2008a). Ad-dnAtg5, Ad-ATP7A-
myc and Ad-GFP-LC3 were generously provided by Dr. Gökhan S. Hotamisligil (Harvard 
School of Public Health) (Yang et al., 2010), Dr. Giuseppe Inesi (California Pacific Medical 
Center Research Institute) (Liu et al., 2010), and Dr. Aviva M. Tolkovski (University of 
Cambridge) (Bampton et al., 2005), respectively. Adenovirus construct to overexpress 
human (h) CTR1 was generated using the Ad-Easy system (He et al., 1998) and hCTR1 
cDNA (Lee et al., 2002). Adenovirus containing only the CMV promoter (Ad-Empty) was 
used as negative control. Adenoviruses were amplified and titered in HEK293T cells as 
described previously (Barde et al., 2010; Rodriguez-Rocha et al., 2012). Cells were infected 
with adenoviral particles at indicated multiplicity of infection (MOI), washed and treated 
under the specified experimental conditions at 24 h post-infection.
Cell death determination
Loss of cell viability was determined by measuring propidium iodide (PI, 1 μg/ml) (Life 
Technologies/Molecular Probes) uptake as a marker for plasma membrane integrity loss. PI 
fluorescence was detected using 488 nm excitation (ex), 695/40 nm emission (em) or 561 
nm ex, 615/25 nm em filters. Apoptosis was determined by assessing the externalization of 
phosphatidylserine using Annexin V. When indicated, cells were washed in PBS and stained 
with Annexin V-Alexa Fluor 488 (1 μl/2.4 × 105 cells, Life Technologies/Molecular Probes) 
in binding buffer (150 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2, 10 mM Hepes 
[pH 7.4]) for 20 min at RT. Alexa 488 fluorescence was recorded using 488 nm ex, 530/30 
nm em filters. When indicated cell shrinkage (apoptotic volume decrease) was determined 
by flow cytometry as changes in the forward scatter light pattern of the cells (Franco et al., 
2008). The forward-angle light scatter relates to cell diameter, i.e. cell shrinkage is reflected 
as a decrease in the amount of forward scattered light. Flow cytometry was performed in a 
BDFACSort (Cytek-DxP-10 upgrade). 10,000 cells were acquired per sample and data were 
analyzed using FlowJo 7.6.5 software. Alternatively, cell death was assessed using Calcein 
retention assay (Life Technologies/Molecular Probes), which measures both the number of 
cells attached and the integrity of the plasma membrane. Cells were incubated with 1 μg/ml 
Anandhan et al. Page 4
Neurobiol Dis. Author manuscript; available in PMC 2016 September 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Calcein-AM for 30 min prior to analysis. Then, cells were washed and analyzed at 485 nm 
ex and 520 nm em in a FLUOstar OPTIMA plate reader (BMG Labtech).
Oxidative stress
Oxidative stress was determined using dihydroethidine (DHE, 5 μM, Life Technologies/
Molecular Probes), which after its oxidization to ethidium intercalates within the DNA and 
exhibits bright red fluorescence (Franco et al., 2007; Rodriguez-Rocha et al., 2013). 
Alterations in the redox state of both cytosol and mitochondrial compartments were 
monitored using the reduction-oxidation sensitive green fluorescent protein (roGFP) sensor 
as done before (Rodriguez-Rocha et al., 2013). When indicated, changes in GSH content 
were determined by flow cytometry using monochlorobimane (mBCl, 10 μM, Life 
Technologies/Molecular Probes). Apoptosis is a stochastic phenomenon (Messam and 
Pittman, 1998), and we have demonstrated that GSH depletion occurs as an asynchronous 
event during cell death progression (Franco and Cidlowski, 2012; Franco et al., 2007). As 
such, GSH depletion determined by flow cytometry is observed as the appearance of a 
population of cells with a decrease in intracellular GSH (i.e. low GSH levels or GSH 
depleted cells) and the concomitant decrease in the number of cells with high (basal) GSH 
levels. A detailed description of these methods can be found in (Franco et al., 2007; 
Rodriguez-Rocha et al., 2013).
Primary midbrain cultures experiments
Primary midbrain cultures were prepared via dissection of E17 embryos obtained from 
pregnant Sprague–Dawley rats (Harlan) as described previously (Liu et al., 2008b). All 
animal procedures were approved by the Purdue Animal Care and Use Committee. The 
mesencephalic region containing the substantia nigra and ventral tegmental area was isolated 
and the cells were dissociated with trypsin (26 μg/ml in 0.9% [w/v] NaCl). Cells were plated 
at a density of 5 × 105 cells in dishes pretreated with poly-l-lysine, 5 μg/ml. Culture media 
consisted of DMEM, 10% (v/v) FBS, 10% (v/v) horse serum, penicillin (100 units/ml), and 
streptomycin (100 μg/ml). Five days after plating, cells were treated with cytosine 
arabinofuranoside (20 μM, 48 h, Sigma/Aldrich) to inhibit the growth of glial cells.
After treatment, cells were fixed in 4% (w/v) paraformaldehyde in PBS (pH 7.4) for 30 min 
and subsequently permeabilized for 1 h (PBS, pH 7.4, 0.3% [v/v] Triton X-100, 1% [w/v] 
bovine serum albumin (BSA), and 10% [v/v] FBS). Then, fixed cells were incubated 
overnight at 4 °C with primary antibodies against MAP2 (1:100, EnCor Biotechnology) and 
TH (1:500, Millipore), washed with PBS, and stained with anti-chicken Alexa Fluor 594 and 
anti-rabbit Alexa Fluor 488 (1:1000, Life Technologies/Molecular Probes) for 1 h at RT. 
ProLong Gold antifade reagent (Life Technologies/Molecular Probes) with the nuclear stain 
4′,6-diamidino-2-phenylindole (DAPI) was applied before adding a coverslip (Liu et al., 
2008a). Relative dopaminergic cell viability was determined by counting MAP2- and TH-
immunoreactive neurons in a blinded manner using a Nikon TE2000-U inverted 
fluorescence microscope (Nikon Instruments) with a 20× objective. The cultures were 
scored for the percentage of MAP2+ neurons that were also TH+ (Liu et al., 2008a; 
Strathearn et al., 2014). Replicate experiments were carried out using embryonic cultures 
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prepared from different pregnant rats. Approximately 500–1000 MAP2+ neurons were 
counted per experiment for each condition.
Yeast strains, plasmids, culturing conditions and growth assays
Saccharomyces cerevisiae W303-1A WT strain (MATa can1-100 ade2-1 his3-1,15 
leu2-3,112 trp1-1 ura3-1) was used in this work. The galactose inducible GAL1 promoter-
driven GFP and the human α-synuclein-GFP expressing strains were generated by 
transformation of WT cells with linearized pFA6a-TRP1-GAL1-GFP and YIp351-SYN-
GFP integrative plasmids (Longtine et al., 1998; Ocampo et al., 2013; Wach et al., 1994) 
kindly provided by Drs. Audrey Atkin (University of Nebraska-Lincoln) and Antoni 
Barrientos (University of Miami) (Ocampo et al., 2013), respectively. Yeast cells were 
cultured in rich YP medium or supplemented with synthetic complete (SC) medium. The 
media contained 2% (w/v) raffinose or 2% (v/v) glycerol-2% (w/v) lactate-0.1% (w/v) 
glucose mix as a sole carbon source. The 2% (w/v) galactose-containing medium was used 
to induce the expression of GFP or α-synuclein. For growth assays, cells were pre-grown in 
2% (v/v) glycerol/(w/v) lactate/glucose SC medium for 12 h at 28 °C, serially diluted and 
dropped onto solid YP plates containing 2% (w/v) raffinose or 2% (w/v) galactose (Sigma/
Aldrich). Plates were then incubated for 2–3 days at 28 °C.
Protein extraction, membrane fraction isolation, electrophoresis and western immunoblot
Isolation of membrane fractions was performed as explained in (Lee et al., 2002) with slight 
modifications. Whole cell lysates were washed with PBS and resuspended in 
homogenization buffer (10 mM Tris-HCl [pH 7.4], 250 mM Sucrose, 2 mM EDTA, Halt 
Protease Inhibitor Cocktail [Thermo Fisher/Pierce]). Cells were homogenized with a 23-
gauge needle (15 passages) and a Dounce homogenizer (50 strokes with a pre-chilled B-type 
pestle). Cell homogenates were centrifuged at 9600 g for 2 min at 4 °C and supernatants 
were collected and centrifuged at 100,000×g for 30 min. The supernatant (cytosolic fraction) 
was collected and the pellet (membrane fraction) was resuspended in buffer (10 mM Tris 
(pH 7.4), 2 mMEDTA, 1% [v/v] Triton X-100) at a final concentration of less than 1 mg of 
protein/ml, and incubated for 30 min on ice. The membrane fraction suspensions were again 
centrifuged at 100,000×g for 30 min at 4 °C. The supernatant was collected and the pellet 
was discarded. The supernatant (containing remaining soluble and detached peripheral 
membrane proteins) and cytosolic fractions were precipitated in TCA (final concentration of 
25% [v/v]). The precipitates were washed twice with ice-cold acetone and resuspended in 
lysis buffer.
Isolation of whole cell lysates, western-immunoblotting (WB) and SDS-PAGE of SK-N-SH 
were performed as explained previously (Rodriguez-Rocha et al., 2012). Blots were 
incubated with the corresponding primary antibodies overnight (1:1000): p-AMPK1α 
(Thr172, 2535), cleaved-caspase 3 (Asp 175, 9661), α-synuclein (2642, carboxy-terminal 
sequence), ubiquitin (3936), and p-Ulk1 (Ser555, 5869) (Cell Signaling); AMPK1α 
(Ab32047), ATP7A (Ab42486), Nrf2 (Ab62352), and Ulk1 (Ab65050) (Abcam); LC3B 
(L7543, SIGMA); and Ctr1 (sc66847, Santa Cruz Biotechnology). Blots were reprobed with 
β-actin (A2228, SIGMA) or GAPDH (2118, Cell Signaling) to verify equal protein loading.
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For analysis of α-synuclein oligomers in soluble and insoluble fractions, cells were initially 
lysed with 10 mM Tris/HCl pH 7.4, 105 mM NaCl, 3 mM MgCl2, 0.1% (v/v) Triton X-100 
and Halt protease inhibitor cocktail containing buffer. Samples were centrifuged at 9,600 g. 
Supernatants (soluble fraction) were analyzed by Blue Native-polyacrylamide gel 
electrophoresis (BN-PAGE). Pellets were lysed in RIPA buffer (0.1% [w/v] sodium dodecyl 
sulfate [SDS], 50 mM Tris-base, 150 mM NaCl, 1% [v/v] Triton X-100. 0.5% [w/v] sodium 
deoxycholate, pH 8.0) and extracts (insoluble fractions) were analyzed by NUPAGE/SDS-
PAGE (Life Sciences/Invitrogen).
Filter trap assay for ubiquitinated protein aggregates
Cells were harvested in RIPA buffer. Samples were sonicated, centrifuged, and pellets 
discarded. Proteins were denatured in LDS-sample buffer (NUPAGE). 25–50 μg of protein 
were filtered in a nitrocellulose membrane previously equilibrated in NUPAGE transfer 
buffer using a dot blotter (Scie-Plas). Membrane was washed twice (2% [w/v] SDS, 10 mM 
Tris-EDTA, pH 7.5) and ubiquitin aggregates were detected by immunoblotting.
Confocal microscopy
Confocal microscopy of GFP-LC3-labeled autophagosomes and MitoTracker Deep Red-
labeled mitochondria in SK-N-SH cells was performed as described previously (Garcia-
Garcia et al., 2013). For visualization of GFP-tagged α-Synuclein in yeast, pre-cultures of 
synchronized S. cerevisiae cells were grown in glycerol/lactate medium overnight and 
transferred into the medium containing 2% [w/v] raffinose or 2% [w/v] galactose with or 
without CuCl2. Live cells and GFP were then visualized with Olympus IX81 inverted 
confocal laser scanning microscope (Olympus America) at 488 nm under oil immersion. 
Images were acquired using Fluoview 500 Software (Olympus America).
Statistical analysis
Experiment replicas were independent and performed on separate days. Collected data were 
analyzed by using one-way, two-way or three-way ANOVA, and the appropriate post-hoc 
test using SIGMA-PLOT/STAT package. When ANOVA assumptions were not met 
(normality or equal variance), Kruskal-Wallis One Way ANOVA on Ranks or data 
transformation (two-way ANOVA) were performed on collected data. Data were plotted as 
mean ± standard error of the mean (SE) using the same statistical package for data analysis. 
Flow cytometry plots and western blots presented show the results of representative 
experiments. Densitometry analyses of WB were performed in Image J (NIH).
Results
Copper induces caspase-dependent apoptosis, which is modulated by Cu content and 
transport
CuCl2 treatment for 48 h induced death in dopaminergic neuroblastoma cells in a dose-
dependent manner (Figs. 1A–B). Cell death was identified by the loss of plasma membrane 
integrity (PI uptake) and the depletion in intracellular GSH content (mBCl) (Figs. 1A–B). 
Cell death was also evaluated by Calcein retention (Fig. 1C). CuCl2-induced cell death was 
significantly reduced in the presence of the irreversible pan-caspase inhibitor z-VAD-FMK 
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(Figs. 1A–C). CuCl2 also induced the cleavage/activation of caspase 3 (Fig. 1D). However, 
inhibition of caspase 3 with Ac-DMQD-CHO had no effect on CuCl2 toxicity (Fig. 1C), 
which might be explained by the compensatory role of other executioner caspases (Zheng et 
al., 2000). The difference between the sensitivity of PI uptake/GSH depletion (Figs. 1A–B) 
and Calcein retention assays (Fig. 1C), to detect the loss in cell viability induced byCuCl2, 
might be related to the fact that Calcein uptake is affected by cell number and proliferation. 
To confirm the occurrence of apoptosis, we evaluated the externalization of 
phosphatidylserine using Annexin V binding to phosphatidylserine. Supplementary Fig. 2A–
B shows that CuCl2 induces a significant increase in early apoptotic (Annexin V+/PI− cells, 
Supplementary Fig. 2A contour plots quadrant 3 [Q3] in broken regions) and late necrotic 
(Annexin V+/PI+ cells, Supplementary Fig. 2A Q1–2). However, the increase in early 
apoptotic cells is no more than 15% of the total population even when high extracellular 
[CuCl2] were used (1 mM), while at this concentration, a reduction of 90% in the normal 
(healthy) population is observed (Annexin V−/PI − cells, Supplementary Fig. 2A–B, Q4). 
This can be explained by the transition of early apoptotic cells (Annexin V+/PI−) to a late 
apoptotic stage (Annexin V+/PI+) (Wlodkowic et al., 2011). Indeed, it has been previously 
demonstrated that in the absence of phagocytes, in charge of the clearance of apoptotic cells/
bodies, cells undergoing apoptosis will progress into a late stage where cell membrane 
becomes permeabilized (i.e. late apoptotic or secondary necrotic cells) (Brauchle et al., 
2014; Silva, 2010).
Externalized phosphatidylserine labeling with Annexin V provides an accurate estimation of 
apoptosis (Wlodkowic et al., 2011), but because it usually labels cells at the very early 
stages of apoptosis, it cannot be used as an accurate measurement of the final outcome of 
apoptotic signaling, which is cell death. Indeed, early apoptotic cells with externalized 
phosphatidylserine can be rescued if the apoptotic stimulus is removed, while loss of plasma 
membrane integrityis anirreversible feature of cell death (Geske et al., 2001). According to 
the Nomenclature Committee on Cell Death the loss of plasma membrane integrity is one of 
the main criteria to define cell death (Kroemer et al., 2009). In addition, several reports 
demonstrated that: 1) programmed cell death can occur without exposure of PS (Fadeel et 
al., 1999; King et al., 2000; Lee et al., 2013); 2) that phosphatidylserine externalization is 
reversible and might be associated to non-cell death processes (Schlegel and Williamson, 
2001; Stowell et al., 2009; Yang et al., 2002); and 3) that phosphatidylserine externalization 
can be regulated in a caspase-independent and -dependent manner (Ferraro-Peyret et al., 
2002; Segawa et al., 2014). The protective effect of the pan-caspase inhibitor z-VAD against 
CuCl2-induced cell death (Figs. 1A–C) clearly points to the occurrence of apoptosis upon 
CuCl2 treatment. While z-VAD cannot fully protect against CuCl2 (Figs. 1A–C), it has been 
demonstrated that distinct cell death mechanisms can be activated simultaneously, and that 
inhibition of one cell death pathway may switch it to a different one (Lemaire et al., 1998; 
McCall, 2010; Yu et al., 2006). Thus, we decided for our further experiments to evaluate 
cell death by assessing the loss of plasma membrane integrity (increased PI uptake and 
reduced Calcein retention) in combination with loss of intracellular GSH (mBCl) to 
determine overall cell death under our experimental conditions. We and others have 
previously demonstrated that GSH depletion is a hallmark of apoptotic cell death (Circu and 
Aw, 2012; Franco and Cidlowski, 2012).
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Intracellular Cu concentrations cannot be dramatically increased in cells treated with high 
extracellular Cu due to the high chelating capacity of components present in the medium 
that are known to form complexes with Cu (Barnea et al., 1989). The requirement for high 
extracellular [CuCl2] to induce cell death might suggest interference from culture media 
components. Albumin in FBS can potently bind copper (Masuoka and Saltman, 1994). Thus, 
it is likely that serum components, including albumin, scavenge copper and reduce its 
availability for uptake by cells. However, a reduction in FBS content in the media had no 
effect on CuCl2-induced cell death (Supplementary Fig. 3A). We next correlated the 
exposure of cells to high [CuCl2] with changes in intracellular Cu content. Cu uptake was 
evaluated by ICP-MS. Supplementary Fig. 3B shows the increase in intracellular Cu induced 
by 1 mM CuCl2. A maximum increase was detected at 24 h that was paralleled by 
significant cell death (> 80%). Thus, we evaluated changes in Cu content after 12 h of 
exposure to increasing concentrations of CuCl2. Supplementary Fig. 3C shows the changes 
in intracellular Cu levels induced by CuCl2. We found that an increase of at least 64 μmole/g 
of protein that corresponded to an exposure of 0.5 mM CuCl2 for 12 h was required to 
induce dopaminergic cell death. Copper chaperone for superoxide dismutase 1 (CCS1) is a 
very sensitive biomarker of copper overload. A significant reduction in CCS, but not 
metallothioneins has been observed after copper supplementation (Suazo et al., 2008). Only 
high extracellular [CuCl2] (>0.5 mM) induced a decrease in CCS1 levels in dopaminergic 
cells (Supplementary Fig. 3D).
To corroborate whether the toxic effects of high extracellular Cu are mediated by changes in 
its intracellular levels, we examined the role of Cu transport systems. In eukaryotic cells, 
high-affinity Cu1+ import is mediated by Ctr1/SLC31A1 (Kim et al., 2008, 2013; Lee et al., 
2002). Ctr1 was found localized in the membrane fraction of two distinct cell clones 
generated “in house” to stably overexpress hCtr1 (Fig. 2A). Transduction of cells with Ad-
Ctr1 significantly increased Cu-induced cell death (Figs. 2C–D). P-type ATPase 
transporters, ATP7A and ATP7B transport Cu ions from the cytosol across cellular 
membranes (Kim et al., 2008). Overexpression of ATP7A (Fig. 2B) did not significantly 
altered CuCl2-induced cell death (Fig. 2E), which might be due to the constant presence of 
high extracellular Cu levels that could surpass the ability of ATP7A to detoxify cells from 
Cu. These results demonstrate that the toxic effects of Cu are linked to alterations in its 
intracellular homeostasis.
Overexpression of WT or A53T α-synuclein increases Cu toxicity independent from 
oxidative stress or α-synuclein aggregation
We next evaluated the toxicity of the α-synuclein missense mutation A53T and the 
overexpression of the WT form as a model for gene multiplication using adenoviral vectors 
(Fig. 3A). No changes in cell survival were detected by short-term (2–3 days) 
overexpression of WT or A53T α-synuclein (Figs. 3B–D). Interestingly, WT or A53T α-
synuclein increased the toxicity of CuCl2 determined by the loss of plasma membrane 
integrity (PI uptake, Fig. 3C and Calcein retention, Fig. 3D) and cell shrinkage, a marker for 
apoptotic cell death (Fig. 3C) (Bortner and Cidlowski, 2004). The synergistic toxic effect of 
Cu exposure and α-synuclein was reproduced in primary midbrain rat dopaminergic cultures 
supplemented with CuSO4 at significantly lower concentrations (10 μM) than those used in 
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the immortalized dopaminergic neuroblastoma cells (SK-N-SH) (Fig. 3E), demonstrating its 
reproducibility in a more physiological setting, and that the synergistic effect is independent 
of the Cu salt used.
We next sought to evaluate if the augmented sensitivity to Cu of cells overexpressing WT or 
A53T α-synuclein was associated with increased oxidative stress. CuCl2 induced oxidative 
stress as evidenced by an increase in ROS formation detected by the oxidation of DHE (Fig. 
4A), which paralleled intracellular GSH loss (Figs. 1A, 2C and 4B) and the up-regulation of 
the nuclear factor (erythroid-derived 2)-like 2 (Nrf2) transcription factor that mediates 
antioxidant response (Fig. 4C). Inhibition of de novo GSH synthesis with BSO (an inhibitor 
of γ-glutamylcysteine ligase) potentiated CuCl2-induced cell death (Supplementary Fig. 4A–
B). To ascertain the contribution of mitochondrial vs cytosolic oxidative stress in Cu toxicity 
and its potentiation by α-synuclein, we used the genetically encoded redox sensitive proteins 
roGFP and its mitochondria-targeted version (Mito-roGFP) (Hanson et al., 2004; Rodriguez-
Rocha et al., 2013). Cu-induced oxidative stress was primarily localized to the cytosolic 
compartment (Figs. 4D–E). However, overexpression of WT or A53T α-synuclein had no 
significant effect on oxidative stress in either the cytosol or mitochondrial compartments 
indicating that the stimulatory effect of α-synuclein on Cu-induced cell death is unlikely to 
arise from oxidative stress.
The toxic effects of α-synuclein are largely ascribed to its aggregation. Cu interacts with α-
synuclein accelerating aggregation and fibril formation, as well as its membrane localization 
(Rasia et al., 2005; Uversky et al., 2001a; X. Wang et al., 2010). We used native and 
denaturing electrophoresis to determine the formation of 1) high molecular weight (HMW) 
Triton X-100 (TX-100)-insoluble and -soluble aggregates of α-synuclein (SDS-PAGE), and 
2) changes in the native conformation of α-synuclein (BN-PAGE) derived from TX-100-
soluble fractions. Overexpression of α-synuclein (WT or A53T mutant) for 72 h, in the 
presence or absence of CuCl2 supplementation did not induce the accumulation of HMW 
aggregates of α-synuclein (Supplementary Fig. 5A [soluble and insoluble fractions] and 5B 
[insoluble fractions]). Under BN-PAGE conditions α-synuclein is reported to exist 
predominantly as stable unfolded monomers that migrate as 57–60 kDa proteins (Fig. 5A, 
upper panel) but in denaturing gels, these monomers migrate as 14 kDa proteins (Fig. 5A, 
lower panel). The larger than expected size of the bands has been proposed to be mainly due 
to the monomers adopting an unfolded extended conformation, which results in a larger than 
expected hydrodynamic radius (Fauvet et al., 2012; Lashuel et al., 2013; Weinreb et al., 
1996). Other research groups proposed that this migration pattern is also a result of a 
fraction of α-synuclein existing as a stable tetramer (Bartels et al., 2011; Dettmer et al., 
2013). CuCl2 treatment caused a decrease in the abundance of this monomer and the 
appearance of a band with enhanced migration (Fig. 5A marked with *), which correlated 
with a decrease in the levels of the monomer determined in TX-100-insoluble fractions (Fig. 
5A, lower panel). These results suggest that Cu does not increase the aggregation of α-
synuclein when this protein is overexpressed only for 72 h. In contrast, we found that Cu 
might mediate changes in the endogenous folded state or stability of α-synuclein (monomer 
or tetramer).
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α-synuclein has been reported to interact to a different extent with membrane compartments 
(Auluck et al., 2010), while its A53T mutant has been shown to accumulate in neuronal 
membrane fractions and induce membrane disruption/permeabilization to a greater extent as 
compared to the WT form (Tsigelny et al., 2012; Volles and Lansbury, 2002). To further 
interrogate whether the synergistic toxic effects of Cu and α-synuclein overexpression are 
linked to changes in α-synuclein aggregation or association with the plasma membrane we 
used the budding yeast S. cerevisiae model overexpressing an inducible promoter-driven 
fusion of α-synuclein-GFP. As reviewed in (Khurana and Lindquist, 2010), yeast provides a 
valid experimental platform to explore the fundamental mechanisms associated with 
neurodegenerative diseases. In this model, the inducible and regulatable expression of α-
synuclein can result in no toxicity, intermediate toxicity, or high toxicity in relation to the 
levels of α-synuclein being expressed. α-synuclein–GFP overexpressed in yeast at non-toxic 
levels localizes to the plasma membrane, consistent with its known affinity with 
phospholipids (Fig. 5B). This is the expected localization of a protein that localizes to 
synaptic vesicles in neurons, when considering that yeast has constitutive vesicular secretion 
(Khurana and Lindquist, 2010). In contrast, GFP overexpression alone results in a diffuse 
localization throughout the cytoplasm (Fig. 5B). Doubling the expression levels of α-
synuclein changes its localization tointracytoplasmic inclusions leading to cytotoxicity, 
consistent with a toxic gain of function (data not shown) (Khurana and Lindquist, 2010). 
Similar to what was observed in the dopaminergic neuroblastoma cell line, the dose-
dependent toxicity induced by Cu in yeast (as reflected by growth inhibition and cell death) 
was stimulated by overexpression of α-synuclein–GFP (Fig. 5C), without any effect on the 
plasma membrane localization of the protein (Fig. 5B). Collectively, these results 
demonstrate that the synergistic toxic effects of α-synuclein overexpression and Cu are not 
associated with the aggregation of the former component.
Cu-induced cell death is regulated by AMPK/Ulk1 signaling and potentiated by inhibition of 
Atg5-dependent autophagy
Autophagy is essential for the constitutive protein and organelle turnover and for cell 
survival during conditions of environmental stress (Murrow and Debnath, 2013). Cu-
dopamine complex induces mitochondrial autophagy (mitophagy) and apoptotic cell death 
(Paris et al., 2009). We observed that CuCl2 induced a dose-dependent accumulation of the 
autophagosome markers GFP-LC3 puncta (Fig. 6A, white arrows) and LC3-II (Fig. 6B). We 
did not observe any co-localization of mitochondria with autophagosome as an indicator of 
mitophagy. LC3-II accumulation was associated with an increase in autophagy flux as 
demonstrated by its enhanced accumulation in the presence of the lysosomal cargo 
degradation (autophagy flux) inhibitor chloroquine (CQ, Figs. 6C–D) (Garcia-Garcia et al., 
2013). The p62/sequestosome 1 (SQSTM1), is a scaffold protein that recognizes 
ubiquitinated protein aggregates and non-ubiquitinated proteins and targets them for 
degradation by autophagy (Bjorkoy et al., 2009). p62 is another marker to study autophagic 
flux and we observed that CuCl2 also induced the accumulation of p62 in a dose-dependent 
manner corroborating the increase in autophagy flux (Fig. 6C).
Collectively, adenosine monophosphate (AMP)-activated protein kinase (AMPK) together 
with mTOR (mammalianor mechanistic target of rapamycin) and Ulk1 (Unc-51-like 
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kinase1) sense the energy and nutrient status of the cell, and dictate the activation of energy- 
and amino-acid-generating catabolic processes such as autophagy (Cardaci et al., 2012; 
Hardie et al., 2012). CuCl2 exposure increases the phosphorylation of AMPK-α1 in a dose-
dependent manner (Fig. 6B). Phosphorylation of Ulk1 at Ser555 by AMPK is critical for 
starvation-induced autophagy and cell survival under conditions of low nutrient and energy 
availability, as well as upon disruption in mitochondrial homeostasis (Egan et al., 2011). We 
found that CuCl2 treatment induced a transient increase followed by a decrease in Ulk1 
phosphorylation (Fig. 6C). Ulk1−/− and DKO -AMPK (α1 and α2)−/− MEFs were more 
sensitive to CuCl2-induced toxicity (Figs. 6E–F). These results suggested that Cu-induced 
AMPK-Ulk1 signaling protects against cell death.
We next sought to understand the role of autophagy in the synergistic toxicity induced by Cu 
and α-synuclein overexpression. The Atg12-Atg5 complex conjugation is essential for 
autophagosome formation, which functions as an E3-like ligase for LC3 lipidation (Hanada 
et al., 2007). Hence overexpression of a dominant negative (dn) form of Atg5 (dnAtg5) is an 
effective approach to inhibit autophagy (Garcia-Garcia et al., 2013; Klionsky et al., 2012; 
Yang et al., 2010). Overexpression of dnAtg5 inhibited autophagy induced by CuCl2 (Fig. 
7A). dnAtg5 increased CuCl2-induced cell death without affecting the survival of cells 
overexpressing WT or A53T α-synuclein treated or not with CuCl2 (Figs. 7B–C). α-
synuclein is known to interfere with autophagic pathways (Martinez-Vicente et al., 2008; 
Winslow et al., 2010). However, we observed that overexpression of WT or A53T α-
synuclein did not affect autophagy flux irrespective of CuCl2 treatment (Figs. 7D–E, n = 3 p 
< 0.05, One-way ANOVA).
Copper induces an increase in protein ubiquitination and inhibition of the proteasome 
stimulates Cu and α-synuclein toxicity
Autophagy and the UPS are major protein quality control mechanisms disrupted in PD 
(Cook et al., 2012). MG132, an inhibitor of the chymotrypsin-like proteasomal activity, 
induces a dose-dependent accumulation of ubiquitinated aggregates in dopaminergic cells 
(Fig. 8A, upper dot blot panel). The half maximal effective concentration (EC50) for the 
accumulation of ubiquitin bound proteins was estimated at 172.8 nM (Supplementary Fig. 
6A), very close to the reported IC50 (100 nM). The levels of ubiquitinated proteins decrease 
48 h after MG132 treatment (Fig. 8A, lower dot blot and WB), which is explained by the 
reported reduction of free ubiquitin levels upon chronic proteasome inhibition (Xu et al., 
2004). Changes in the HMW ubiquitinbound proteins in cells treated with CuCl2 were 
evaluated in the presence of MG132, to distinguish whether alterations were linked to 
changes in proteasomal activity or protein ubiquitination. CuCl2 induced an increase in 
ubiquitinated proteins in the presence or absence of MG132, demonstrating that their 
accumulation is linked to increased ubiquitination. (Fig. 8B WB and dot blot, and 
Supplementary Fig. 6B). MG132 enhanced CuCl2 toxicity whether WT or A53T α-
synuclein were overexpressed or not (Supplementary Fig. 6C and Fig. 8C). Neither WT nor 
A53T α-synuclein overexpression had an effect on the accumulation of ubiquitinated 
proteins (Fig. 8D, WB and dot blot, n = 3 p < 0.05 One-way ANOVA). Interestingly, in the 
presence of the proteasome inhibitor MG132, WT or A53T α-synuclein markedly increased 
ubiquitinated-protein levels (Fig. 8E and Supplementary Fig. 6D). These results demonstrate 
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that while impairment of autophagy only enhanced Cu toxicity, inhibition of proteasomal 
activity enhanced both Cu and Cu + α-synuclein toxicity. In addition, WT or A53T α-
synuclein stimulated protein ubiquitination but did not affect autophagy flux.
Both autophagy and the UPS may act simultaneously in the degradation of α-synuclein. We 
next decided to evaluate the contribution of both degradation pathways to α-synuclein 
accumulation. In contrast to CuCl2 treatment (Supplementary Fig. 5), inhibition of 
proteasomal activity increased the accumulation of HMW α-synuclein aggregates isolated 
from total cell lysates (Supplementary Fig. 7A), and TX-100-insoluble fractions 
(Supplementary Fig. 7B) Inhibition of autophagy per se had no effect on the accumulation of 
HMW (Supplementary Fig. 7A–B). Simultaneous inhibition of autophagy and the 
proteasome only potentiated the accumulation of HMW aggregates in cells expressing WT 
α-synuclein in triton soluble fractions, but not A53T (Supplementary Fig. 7B). Similar to 
CuCl2 treatment, inhibition of the proteasome but not autophagy induced an accumulation of 
a protein band with a lower migration profile in cells overexpressing either WT or A53T 
forms (Supplementary Fig. 7C, highlighted by *). This effect was potentiated by expression 
of dnAtg5. Impairment of both autophagy and the proteasome had no additive effect on the 
toxicity of CuCl2 in the presence or absence of either α-synuclein or A53T (Supplementary 
Fig. 8). Our results suggest then that Cu can exert a synergistic toxic effect with WT or 
A53T α-synuclein independent from α-synuclein aggregation. This synergistic effect seems 
to be mediated by an increase “stress load” to protein degradation mechanisms, primarily the 
ubiquitin/proteasome system and, to a lesser extent, autophagy (Supplementary Fig. 9).
Discussion
Mutations or multiplications in SNCA and the oligomerization, aggregation and 
accumulation of its protein product (α-synuclein) have been linked to PD. However, the 
mechanisms by which α-synuclein contributes to the loss of dopaminergic neurons are 
unclear. Dysregulation of intracellular metal homeostasis has been suggested as a likely 
contributor to PD (Ayton et al., 2012; Bharucha et al., 2008). In the present study, we 
demonstrated that non-toxic α-synuclein overexpression can increase the sensitivity of cells 
to Cu. While previous studies have demonstrated that Cu can promote α-synuclein 
aggregation, we found that the increased sensitivity to Cu of cells overexpressing α-
synuclein is independent from its aggregation or oxidative stress. Interestingly, impairment 
of autophagy flux only increased Cu toxicity, while inhibition of the UPS enhanced the 
toxicity induced by Cu and Cu + α-synuclein. Our results demonstrate that α-synuclein 
enhances Cu toxicity in dopaminergic cells via modulation of protein degradation pathways 
(Supplementary Fig. 9).
Cu mediates oxidation-reduction reactions participating in the generation of ROS and 
subsequent oxidative damage. Indeed, we observed that Cu induced caspase-dependent 
apoptotic cell death in dopaminergic cells was associated with increased oxidative stress. 
Chronic intracellular accumulation of misfolded α-synuclein also promotes oxidative stress 
and mitochondrial dysfunction (Hsu et al., 2000), and α-synuclein-Cu complexes trigger 
ROS formation (Meloni and Vasak, 2011; C. Wang et al., 2010). Moreover, α-synuclein 
also potentiates oxidative stress induced by pesticides (Kanda et al., 2000; Ko et al., 2000). 
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However, by using redox sensitive reporters we observed that WT or A53T α-synuclein 
overexpression had no significant effect on cytosolic or mitochondrial oxidative stress 
induced by Cu.
The extracellular Cu concentrations used in this work to induce cell death in dopaminergic 
neuroblastoma cells are high (500–750 μM) compared to those found in the CSF of PD 
patients (0.3 μM). Cu-induced toxicity has been shown to be potentiated by dopamine (Paris 
et al., 2001, 2009). The human SK-N-SH neuroblastoma cell line used here has been 
reported to have low levels of tyrosine hydroxylase activity (Klongpanichapak et al., 2008; 
West et al., 1977). Tyrosine hydroxylase levels in human neuroblastoma cells can be 
increased by their differentiation with retinoic acid, but their differentiation can makethem 
resistant to cell death by upregulation of anti-apoptotic signaling mechanisms (Cheung et al., 
2009). Dopamine increases the sensitivity of dopaminergic cells to PD-related insults. Thus, 
the reduced sensitivity of the neuroblastoma cells to Cu + α-synuclein might be due to 
reduced dopamine content. Dopamine and/or its metabolites promote α-synuclein 
aggregation and toxicity and concomitantly, α-synuclein deregulates dopamine homeostasis 
(Conway et al., 2001 ; Lotharius and Brundin, 2002; Xu et al., 2002). The synergistic toxic 
interaction found in our experimental paradigm seems to be independent from α-synuclein 
aggregation. However, the pro-oxidant properties of dopamine might promote the 
synergistic toxicity induced by Cu + α-synuclein independent from α-synuclein 
oligomerization or aggregation. As such, we could reproduce the synergistic toxicity of Cu 
and α-synuclein in primary midbrain neuronal cultures using significantly lower 
concentrations of Cu (10 μM). Interestingly, localized Cu release from synaptic clefts was 
estimated to reach ~ 10–100 μM during neuronal activity (Hopt et al., 2003; Kardos et al., 
1989).
The brain contains the highest Cu content in the body next to the liver (6–20 μg/g dry 
weight) (Kornhuber et al., 1994; Prohaska, 1987). Primary cortical neurons are reported to 
contain ten times higher levels of Cu than astrocytes (200 μg/g of protein) (Hare et al., 
2013). The substantia nigra (59 μg/g dry weight) and the locus coeruleus (201 μg/g dry 
weight), where neuronal loss in PD is reported to be greater than in the substantia nigra 
(Zarow et al., 2003), contain higher concentrations of Cu compared to other brain regions 
(<35 μg/g dry weight) (Davies et al., 2013b; Lutsenko et al., 2010; Prohaska, 1987). At least 
500 μM CuCl2 was required in our study to induce synergistic toxicity in dopaminergic cells 
when combined with α-synuclein overexpression. High extracellular Cu concentrations can 
exert nonspecific effects through alterations in membrane function and stability. However, 
in our experimental model exposure to 500 μM CuCl2 only correlated with an increase in Cu 
from 1.3 μg (0.02μmole) under normal conditions, to 64 μg/g of protein (1 μmole Cu/g 
protein). Thus, the intracellular Cu levels required to potentiate cell death in the presence of 
α-synuclein are similar to the levels found in the substantia nigra.
DMEM:F12 media formulation contains 5.2 nM CuSO4. Thus, a 10,000 fold increase in 
extracellular Cu (500 μM) is only translated to a 50 fold increase in intracellular Cu levels, 
suggesting that a limited permeability for translocation of Cu across the plasma membrane 
or an active efflux mechanism maintain intracellular Cu homeostasis. Importantly, this 
threshold is based on a dose-response, not a time course analysis. Thus, longer exposures to 
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Cu might be required for lower concentrations of Cu to overcome cellular “defenses” and 
induce toxicity. Accordingly, we observed that overexpression of Ctr1 increased Cu-induced 
cell death demonstrating that the toxic effects of high extracellular Cu are mediated by 
changes in its intracellular levels. Interestingly, a recent report demonstrates that low levels 
of Ctr1 are found in survival neurons in the substantia nigra of PD patients (Davies et al., 
2013a).
Another possibility for the requirement of high extracellular Cu levels to induce toxicity is 
likely associated with the very effective intracellular chelating systems for Cu, such as 
methallothioneins, metallochaperones and GSH (Meloni and Vasak, 2011; White et al., 
1999). GSH depletion is an early biomarker of PD progression observed prior to any major 
alterations in metal homeostasis (Dexter et al., 1994; Pearce et al., 1997). GSH depletion/
oxidation increases α-synuclein expression and aggregation (Y.H. Kim et al., 2011; Paik et 
al., 2003). Similarly, Cu-induced α-synuclein aggregation is enhanced by GSH depletion 
(Cheng and Trombetta, 2004). We found that GSH depletion significantly increased Cu-
induced cell death. Metallothioneins exert protective effects against toxicological models of 
PD including oxidative stress inducedby α-synuclein complexes (Meloni and Vasak, 2011). 
Cu/metallothionein or Cu/ceruloplasmin ratios in plasma are not indicative of PD disease 
progression (Arnal et al., 2010). However, variations in ceruloplasmin synthesis and/or its 
Cu-binding properties have been proposed as essential features of PD (Bharucha et al., 2008; 
Torsdottir et al., 1999) and mediators of α-synuclein aggregation in vitro (Kim et al., 2002). 
It is important to note that the pathological consequences Cu are not necessary linked to the 
total amount of Cu in the cells but rather to the labile Cu pool available.
Dopamine (Gomez-Santos et al., 2003), neuromelanin (Li et al., 2012), environmental 
toxicants including pesticides (paraquat, dieldrin, rotenone) (Manning-Bog et al., 2002; 
Mulcahy et al., 2012; Sherer et al., 2003; Sun et al., 2005; Uversky et al., 2001b) and metals 
(Cu, Fe and Al) (Ostrerova-Golts et al., 2000; VanDuyn et al., 2013; X. Wang et al., 2010), 
as well as mitochondrial toxicants (MPTP/MPP+) (Fornai et al., 2005) can induce 
dopaminergic cell death and/or potentiate WT or mutant α-synuclein toxicity by increasing 
its expression levels or aggregation. α-synuclein oligomerization and fibrillogenesis are also 
modulated byphosphorylation, C-terminal truncations and interactions with metals or pro-
oxidant conditions (Breydo et al., 2012; Stefanis, 2012). A number of studies have reported 
that Cu interacts with α-synuclein accelerating aggregation and fibril formation and also 
modulating its membrane localization (Bortolus et al., 2010; Rasia et al., 2005; Rose et al., 
2011; Uversky et al., 2001a; X. Wang et al., 2010). The neurotoxicity of α-synuclein was 
also postulated to require Cu (Wright et al., 2009). Our data show that while inhibition of the 
proteasome increased the accumulation of HMW aggregates of WT or A53T α-synuclein, 
Cu had no major effects on either α-synuclein aggregation or membrane localization when 
the latter was overexpressedin ashort-term/non-toxic manner. These results are explained by 
the fact that formation of HMW aggregates in cells takes ~7 days of α-synuclein over-
expression (Ko et al., 2008). Thus, our results do not necessarily contradict the well-
establish stimulatory effect of Cu on α-synuclein aggregation. Instead, we report that 
overexpression of WT or A53T α-synuclein can also exert synergistic effects with Cu via 
modulation of protein degradation pathways. Most of the studies so far have associated the 
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toxicity of α-synuclein overexpression and mutation to its aggregation. Interestingly, it was 
demonstrated that the toxicity of α-synuclein overexpression in a conditional mouse model 
is independent from filamentous inclusion body formation (Nuber et al., 2008). Very few 
studies exist to date that report on the effects of non-toxic/low expression levels of α-
synuclein and its deleterious effects irrespective of its aggregation. Non-toxic 
overexpression of A30P α-synuclein lowers proteasomal activity and increases the intrinsic 
pathway of apoptosis (Tanaka et al., 2001). To the best of our knowledge, this is the first 
report demonstratingthat non-toxic α-synuclein overexpression can have deleterious effects 
by synergizing with metal toxicity (Cu) and proteasome dysfunction.
Endogenous α-synuclein is found natively unfolded and soluble in the cytoplasm, with a 
small fraction associated with lipid membranes. An interesting observation in our work was 
that both excess Cu and proteasome inhibition seem to alter the native conformation of α-
synuclein. It has been demonstrated that α-synuclein exists predominantly as stable unfolded 
monomer or a tetramer that migrates as 57–60 kDa protein under native conditions. We 
found that both Cu and inhibition of the proteasomal activity induced the appearance of 14 
kDa protein band under native conditions suggesting that Cu may be inducing either: 1) an 
alteration in the native conformation; 2) changes in the oligomerization (tetramerization) 
state; or 3) cleavage of α-synuclein. Furthermore, α-synuclein in such “modified state” 
appears to be more proteasomal degradation-prone, as suggested by its accumulation in the 
presence of MG132. Native α-synuclein has been proposed to exist in equilibrium between 
different conformational and/or oligomeric states (Lashuel et al., 2013), and the stable native 
state may prevent α-synuclein from forming toxic oligomers. Thus, the synergistic effect of 
Cu and α-synuclein (WT or A53T) overexpression might be linked to alterations 
(destabilization) in the protein’s non-toxic state. Consistent with this idea, proteases such as 
calpain, cathepsins or metalloproteases are known to cleave α-synuclein (Dufty et al., 2007), 
and the resulting C-terminal truncations have been shown to enhance α-synuclein toxicity 
(Burre et al., 2012). Identifying the nature of this modified/destabilized state and the 
mechanisms mediating its accumulation by Cu exposure or by inhibition of the proteasome 
will require more research.
Clearance of WT and/or A53T α-synuclein aggregates has been shown to be mediated by 
both autophagy and the ubiquitin/proteasome pathway (Cuervo et al., 2004; Ebrahimi-
Fakhari et al., 2011 ; Webb et al., 2003). Reciprocally, α-synuclein can interfere with 
autophagy (Martinez-Vicente et al., 2008; Winslow et al., 2010) and the ubiquitin/
proteasome system (Chen et al., 2005; Lindersson et al., 2004; Martin-Clemente et al., 2004; 
Snyder et al., 2003; Tanaka et al., 2001; Zhang et al., 2008). For example, WT and A53T α-
synuclein variants inhibit autophagy via impairment of the cytosolic translocation of the 
high mobility group box 1 (HMGB1), reducing HMGB1-beclin-1 binding, and increasing 
Beclin-1-Bcl-2 association (Song et al., 2014), as well as by a decrease in the activity of the 
transcriptional regulator of the autophagy-lysosome pathway, TFEB (transcriptional factor 
EB) (Decressac et al., 2013). Oxidation of α-synuclein has been reported to reduce its 
degradation by the 20S proteasome (Alvarez-Castelao et al., 2013). Cu has been recently 
shown to induce the aggregation of ubiquitin (Arnesano et al., 2009). We found that Cu 
induced both an increase in protein ubiquitination and autophagy. The accumulation of 
ubiquitinated proteins induced by Cu was not associated with impairment in the proteasome 
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pathway as evidenced by its enhancement in the presence of MG132, and its non-saturable 
kinetic in the presence or absence of the proteasome inhibitor. Overexpression of WT or 
A53T α-synuclein also stimulated both autophagy and the accumulation of ubiquitinated 
proteins. Because impairment of autophagy only enhanced Cu toxicity, while inhibition of 
the proteasome enhanced both Cu and WT/A53T α-synuclein toxicity, our results suggest 
that α-synuclein exerts its effect primarily via modulation of the UPS.
Autophagy is a catabolic process involved in cellular survival during conditions of 
environmental stress (Murrow and Debnath, 2013). In very few circumstances there is actual 
genetic-based evidence for a role of autophagy as a cell death pathway (Shen et al., 2012). 
We found that the AMPK-Ulk1 signaling and Atg5-dependent autophagy exerted a 
protective effect against Cu-induced apoptosis. While macroautophagy (here referred to as 
autophagy) depends on the formation of the Atg12-Atg5 conjugation system for 
autophagosome formation, chaperone-mediated autophagy (CMA) involves the direct 
delivery of substrates to the lysosome via recognition of specific chaperones (Kroemer et al., 
2010). Both autophagy and CMA have been reported to mediate the clearance of α-
synuclein (Cuervo et al., 2004; Malkus and Ischiropoulos, 2012; Vogiatzi et al., 2008). Our 
data cannot completely rule-out the role of autophagic processes in the synergistic toxic 
effects of Cu and α-synuclein because previous studies have showed that impaired 
macroautophagy leads to constitutive activation of CMA (Kaushik et al., 2008).
Overall, our work demonstrates, for the first time, that Cu exposure and α-synuclein (WT or 
A53T) exert a synergistic toxic effect on dopaminergic cells independent from α-synuclein 
aggregation. Our data also suggest that this synergistic effect is mediated by an increased 
“stress burden” to protein degradation mechanisms, primarily the UPS, and, to a lesser 
extent autophagy (Supplementary Fig. 9). The toxic effects of Cu/proteasome dysfunction 
and α-synuclein might be associated with alterations in the native state of the monomer.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Abbreviations
A53T mutant A53T α-synuclein
AMPK adenosine monophosphate (AMP)-activated protein kinase
Atg5 autophagy protein 5
ATP7A Cu-transporting ATPase 1
BSO L-buthionine-sulfoximide
Ctr1 Cu transporter protein 1
Cu copper
CuCl2 copper chloride
CuSO4 copper sulfate
CMA chaperone-mediated autophagy
CQ chloroquine
DHE dihydroethidine
DMSO dimethyl sulfoxide
EDTA ethylenediaminetetraacetic acid
FBS fetal bovine serum
PBS phosphate-buffered saline
FRE ferric reductase
GSH glutathione
HMW high molecular weight
ICP-MS Inductively Coupled Plasma Mass Spectrometry
LC3 microtubule-associated protein 1A/1B-light chain 3
mBCl monochlorobimane
MEFs mouse embryonic fibroblasts
MOI multiplicity of infection
MR metalloreductasesNrf2, nuclear factor (erythroid-derived 2)-like 2 (Nrf2) 
transcription factor
PD Parkinson’s disease
PI propidium iodide
roGFP reduction-oxidation sensitive green fluorescent protein
ROS reactive oxygen species
SNCA/PARK1 synuclein, alpha (non A4 component of amyloid precursor)/Parkinson 
disease, familial, type 1 gene
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STEAP six-transmembrane epithelial antigen protein
TBS tris-buffered saline
Ulk1 Unc-51-like kinase 1
UPS ubiquitin-proteasome system
WT wild type
z-VAD-FMK carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl]-fluoromethylketone
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Fig. 1. 
Copper exposure induces apoptosis in dopaminergic cells. In A–B, cell survival after CuCl2 
treatment (48h) was determined in cells co-stained with PI and mBCl. Two-dimensional 5% 
probability contour plots in A display cell death (PI uptake) vs GSH content (mBCl). 
Healthy cells were identified as PI- and high mBCl fluorescence (broken line regions in A) 
and quantified in the corresponding bar graphs in B. Numbers in quadrants (A) reflect 
number of cells in %. In C, well death was evaluated via Calcein retention assay and data 
was normalized vs control (DMSO). When indicated, cells were pre-treated with 50 μM pan-
caspase (Z-VAD-FMK) or caspase 3 inhibitor (DMQD-CHO) for 1 h and inhibitors 
remained present throughout the experiment. In D, WB analysis of CuCl2-induced caspase 3 
cleavage/activation. Numbers (italics) represent the densitometry analysis of cleaved 
caspase 3 normalized to β-actin signal with respect to control. The WB is cropped for 
simplification, but the unmodified version is found in Supplementary Fig. 1. Data in graphs 
represent means ± SE of at least n = 3. Two-way ANOVA, Holm-Sidak post hoc test, ap < 
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0.05 vs DMSO only; bp < 0.05 zVAD or Ac-DMQD vs DMSO within the corresponding 
[CuCl2] category.
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Fig. 2. 
Copper transport regulates cell death. In A, cytosolic and membrane fractions were extracted 
from two stable cell clones overexpressing hCtr1, and its expression levels were evaluated 
by WB. In B, whole cell lysates of cells transduced at the indicated MOI for 24 h with Ad-
Empty or Ad-ATPA-myc were isolated, and the expression levelsof ATP7A were confirmed 
with anti-ATP7A (left panel) or anti-myc (right panel) antibodies. In C–E, cells were 
transduced with Ad-Empty, Ad-hCtr1 or Ad-ATPA-myc at the indicated MOI for 24 h. 
Then, cells were washed and treated with CuCl2 for 48 h. Cell death was determined by the 
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PI uptake and the loss of in intracellular GSH as explained in Fig. 1A. In C, results were 
represented in two-dimensional 5%probability contour plots displaying cell death (PI 
uptake) vs GSH content (mBCl). Healthy cells were identified asPI- and high mBCl 
fluorescence (broken line regions). Numbers in quadrants reflect %s. Data in D and E is 
expressed as cell survival (i.e. % of cells with normal GSH content and PI- after treatments). 
Two-way ANOVA, Holm-Sidak post hoc test, ap < 0.05 vs Empty without CuCl2 
supplementation, bp < 0.05 vs Empty within the corresponding [CuCl2] category. n.s. not 
significant.
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Fig. 3. 
Non-toxic overexpression of α-synuclein sensitizes dopaminergic neuroblastoma cells and 
primary midbrain cultures to Cu toxicity. In A and B, neuroblastoma cells were transduced 
with Ad-Empty, Ad-α-synuclein or Ad-α-synuclein A53T mutant (A53T) at the indicated 
MOI for 24 h. Cells were washed, and the expression levels of WT or A53T α-synuclein 
were measured by WB after 48 h of transduction (A), while cell survival was evaluated by 
Calcein retention (B). In C and D, cell death induced by CuCl2 treatment (48 h, 0.75 mM in 
C) was determined in neuroblastoma cells previously transduced with WT or A53T α-
synuclein using PI uptake (C) or Calcein retention assay (D). In C, cell death is represented 
in two-dimensional 5% probability contour plots of PI fluorescence vs cell size (forward 
scatter) to depict cells with both compromised plasma membrane integrity (PI uptake) and 
decreased cell size. %s in contour plots represent the number of viable cells (PI- and normal 
cell size, broken line regions). Data in B and D represent means ± SE of n = 3. In E, primary 
midbrain cultures transduced, or not, with WT α-synuclein (MOI = 10, 72 h) were incubated 
in fresh media with or without CuSO4 (10 μM) for 24 h. Cells were stained with antibodies 
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specific for MAP2 and TH and scored for dopaminergic cell viability. The data are 
presented as the mean ± SE of n = 7. Two-way ANOVA, Holm-Sidak post hoc test, ap < 
0.05 vs Empty without CuCl2 or CuSO4 supplementation; bp < 0.05 vs 0 mM CuCl2 within 
the corresponding category of α-synuclein or A53T; cp < 0.05 vs Empty within the 
corresponding [CuCl2] tested.
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Fig. 4. 
The synergistic toxic effect of α-synuclein and CuCl2 is not mediated by increased oxidative 
stress. Cells were treated with increasing concentrations of CuCl2 for 48 h. ROS formation 
and GSH depletion were determined by DHE oxidation (A) and changesin mBCl 
fluorescence (B), respectively. InC, whole cell lysates of cells treated with CuCl2 were 
isolated to determine changes in Nrf2 levels by WB. Numbers (italics) represent the 
densitometry analysis normalized to β-actin with respect to control. In D–E, stable cells 
overexpressing roGFP and Mito-roGFP were transduced with Ad-Empty, Ad-α-synuclein or 
Ad-A53T for 24 h (3 MOI). Then, cells were washed and treated with CuCl2 (48 h) as 
indicated. Cells were stained with PI and only viable cells (PI−) were analyzed to determine 
alterations in the cytosolic (roGFP) or mitochondrial (Mito-roGFP) redox state by 
ratiometric analysis. Data in graphs were normalized with respect to Empty control values. 
Data in graphs represent means ± SE of n = 3 independent experiments. One-way ANOVA, 
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Holm-Sidak post hoc test, ap < 0.05 vs 0 mM CuCl2. Two-way ANOVA, Holm-Sidak post 
hoc test, bp < 0.05 vs 0 mM CuCl2 within the corresponding virus category.
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Fig. 5. 
The synergistic toxic effect of α-synuclein and CuCl2 is not associated with changes in α-
synuclein aggregation. In A, cells were transduced with Ad-Empty, Ad-α-synuclein or Ad-
A53T for 24 h (3 MOI), washed and then treated with or without CuCl2 (48 h). TX-100-
soluble (upper panel) and insoluble (lower panel) fractions were analyzed by BN- and SDS-
PAGE, respectively, and α-synuclein was visualized by WB. Numbers (italics) represent the 
densitometry analysis normalized to β-actin with respect to the corresponding control. In B–
C, W303 wild type S. cerevisiae strains containing genome-integrated, GAL1 promoter-
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driven GFP or α-synuclein-GFP expression cassettes were pre-grown in 2% glycerol (v/v)/ 
lactate (w/v) medium, serially diluted and spotted onto plates containing either 2% raffinose 
or 2% galactose (w/v) as a sole carbon source, and supplemented with the indicated amounts 
of CuCl2. Cells were incubated for 2 days at 28 °C. In B, visualization of GFP and α-
synuclein-GFP distribution was assessed by confocal microscopy performed after 12 hours 
of cell growth in the indicated medium with or without 4 mM CuCl2.
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Fig. 6. 
Copper increases autophagy flux and its toxicity is regulated by AMPK-Ulk1 signaling. In 
A, autophagosome formation induced by 0.75 mM CuCl2 (48 h) was analyzed by confocal 
microscopy in cells transduced with Ad-GFP-LC3 (3 MOI, 24 h prior CuCl2 treatment). 
Mitochondria were labeled with Mitotracker. In B, accumulation of LC3-II, and 
phosphorylation of AMPKα1 and Ulk1 (Ser555) in response to increasing concentrations of 
CuCl2 (48 h) was evaluated by WB. In C and D, accumulation of LC3-II and p62 induced by 
CuCl2 (48 h) was determined in the presence or absence of chloroquine (CQ, 40 μM, 4 h 
prior sample harvesting). Numbers in B, C (italics) represent the densitometry analysis with 
respect to total AMPKα1, Ulk 1 or β-actin (for LC3-II) and normalized to the corresponding 
control ± CQ. Data in D represent the densitometry analysis of LC3-II with respect to 
control + CQ and are means ± SE of n = 3 independent experiments. Controls contained 
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DMSO used as vehicle for CQ. In E–F, Ulk1−/−, DKO AMPK−/− or the corresponding WT 
MEFs were exposed to CuCl2 at the concentrations indicated (48 h). Cell viability was 
determined by simultaneous analysis of both PI uptake and changes in intracellular GSH 
(mBCl) by flow cytometry as exemplified in Fig. 1A. Viable cells were defined as cells with 
high intracellular glutathione levels (GSH) and PI-. %s represent means ± SE of n = 3 
independent experiments. One-way ANOVA, Holm-Sidak post hoc test, ap < 0.05 vs control 
0 mM CuCl2. Two-way ANOVA, Holm-Sidak post hoc test, bp < 0.05 vs WT 0 mM 
CuCl2 cp < 0.05 vs WT within the corresponding [CuCl2] tested.
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Fig. 7. 
Inhibition of Atg5-dependent autophagy increases Cu toxicity but not the synergistic toxicity 
of Cu/α-synuclein. Cells were transduced with Ad-dnAtg5 (1.5 MOI) and/or Ad-α-synuclein 
or Ad-A53T (3 MOI) for 24 h. Ad-Empty was used as control at the MOI required to 
normalized the MOI used for other treatments (4.5 MOI total), In A, D and E, autophagy 
(LC3-II accumulation) induced by 0.75 mM CuCl2 (48 h) was evaluated by WB. In D–E, 
autophagy flux was determined by incubation with CQ (40 μM) 4 h prior to sample 
isolation. Controls contained DMSO usedas vehicle for CQ. Numbersin WBs (italics) 
Anandhan et al. Page 38
Neurobiol Dis. Author manuscript; available in PMC 2016 September 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
represent the densitometry analysis normalizedto β-actin with respect to controls± CQ. In C, 
cell death induced by 0.75 mM CuCl2 (48 h) is represented in two-dimensional 5% 
probability contour plots of PI fluorescence vs cell size (forward scatter) to depict cells with 
both compromised plasma membrane integrity (PI uptake) and decreased cell size. %s in the 
contour plots represent the population of viable cells (PI- and normal cell size, broken line 
regions). B: Two-way ANOVA, Holm-Sidak post hoc test was performed only on CuCl2 
data, ap < 0.05 vs Empty + CuCl2; (with or without dnAtg5 transduction); bp < 0.05 vs -
dnAtg5 within the corresponding virus category (empty, α-synuclein or A53T).
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Fig. 8. 
Inhibition of proteasomal activity increases Cu and α-synuclein toxicity. Accumulation of 
ubiquitin-bound proteins was evaluated by WB or dot blot. Numbers in dot blots (italics) 
represent the densitometry analysis normalized to β-actin with respect to the indicated 
controls. In A, cells were treated with MG132 as indicated. In B, cells were treated initially 
with CuCl2 for 24 h and then MG132 was added for 24 h (CuCl2 remained throughout the 
experiment). In C, cells were transduced with the indicated viral vectors for 24 h. Then cells 
were washed and treated with CuCl2 ± MG132 for 48 h. Cell viability was determined by 
simultaneous analysis of both PI uptake and changes in intracellular GSH (mBCl) by flow 
cytometry as exemplified in Fig. 1A. Viable cells were defined as cells with high 
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intracellular GSH levels and PI−. %s represent means ± SE of n = 3 independent 
experiments. Three-way ANOVA, Holm-Sidak post hoc test, ap < 0.05 vs Control within the 
corresponding category of virus ± MG132;bp < 0.05 vs Empty within the corresponding 
category ± CuCl2 ± MG132. In D, cells were transduced with the indicated viral vectors for 
24 h, washed, and then treated with CuCl2 for 48 h. In E, cells were transduced with the 
indicated viral vectors for 24 h, washed, and after 24 h, treated with MG132 for additional 
24 h (72 h total). Controls contained DMSO used as vehicle for MG132.
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Supplementary Figure 1. Unmodified WB 
from Figure 1D (uncropped). Upper film was 
developed using anti-cleaved caspase 3 (*) 
(Asp175), while bottom image was obtained 
after the same film was reprobed and 
developed with anti--actin antibody. 
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staining with PI and Annexin V-Alexa 488 (externalized phosphatidylserine). Results are 
represented as two-dimensional 5% probability contour plots displaying cell death (PI uptake) 
vs externalized phosphatidylserine (Annexin V) (A) . The number of viable “healthy’ cells 
(Annexin V- / PI-, quadrant 4 [Q4]), early apoptotic cells (Annexin V+ / PI-, Q3), and late 
apoptotic (secondary necrosis, Annexin V+ / PI+, Q1 and Q2) cells was quantified and 
represented in scatter plots in B. % of early apoptotic cells is represented with an 
independent y axis (left). Data represent means ± SE of at least n = 3. Kruskal-Wallis one-
Way ANOVA on Ranks, Student-Newman-Keuls post hoc test, ap<0.05 vs 0 mM CuCl2 for 
each population category. 
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cells with increased PI uptake or GSH depletion (A). Healthy cells (PI- and  high mBCl fluorescence) 
are depicted in broken line regions. In B-C, changes in intracellular Cu content induced by CuCl2 were 
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one-Way ANOVA on Ranks, Student-Newman-Keuls post hoc test, ap<0.05 vs 0mM CuCl2. In D, 
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the densitometry analysis of CCS normalized to -actin signal with respect to control.  
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Supplementary Figure 6. In A, four parameter logistic fit curve for the densitometry 
analysis of the accumulation of ubiquitin-bound proteins induced by MG132 (Figure 
8A, upper dot blot). Intersecting lines depict EC50 for the induced accumulation of 
ubiquitin-bound proteins. Data were normalized with respect to control (see 
densitometry analysis in Figures 8A-B). In B and D, densitometry analysis of the 
accumulation of ubiquitin-bound proteins induced by CuCl2 (Figures 8B) or by 
overexpression of α-synuclein (WT or A53T mutant) (Figures 8D), respectively, in the 
presence or absence of MG132. In C, changes in cell survival upon CuCl2 treatment in 
the presence or absence of MG132 (48 h). Cell viability was determined by 
simultaneous analysis of both PI uptake and changes in intracellular GSH (mBCl) by 
flow cytometry as exemplified in Figure 1A. Viable cells were defined as cells with 
high intracellular glutathione levels (GSH), and PI-. %s represent means ± SE of n = 3 
independent experiments.  Two-way ANOVA, Holm-Sidak, ap<0.05 vs -CuCl2 within the 
corresponding category  MG132; bp<0.05 vs - MG132 within the corresponding 
[CuCl2]; cp<0.05 vs Empty within the corresponding [MG132] category. 
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Supplementary Figure 7. Cells were transduced with Ad-Empty, Ad-α-synuclein or Ad-A53T 
(3 MOI). After 48 h, cells were washed and treated with 0.2 µM MG132 for 24 h. Total lysates 
(RIPA / SDS-PAGE) (A) and TX-100-insoluble (RIPA solubilization of post-TX-100 extracts / 
SDS-PAGE, B) or soluble (TX-100 / Blue Native-PAGE, C) fractions were isolated and 
analyzed as explained in Materials and Methods. α-synuclein was detected with a carboxy-
terminal directed antibody. Numbers (italics) represent the densitometry analysis normalized to 
-actin with respect to the corresponding control. 
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Supplementary Figure 8. Cells were transduced with Ad-Empty or Ad-dnAtg5 (1.5 MOI) and/or 
Ad-Empty, Ad-α-synuclein or Ad-A53T (3 MOI) for 24h, washed and then treated with or without 
CuCl2  MG132 (0.2 µM) for 48 h before analysis. Alterations in cell viability were determined by 
analysis of PI uptake by flow cytometry. Viable cells are defined as cells with high PI 
fluorescence. %s represent the population of viable cells (right region) or dead cells (left region). 
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Supplementary Figure 9. WT or A53T α-synuclein overexpression stimulates Cu toxicity 
by modulation of protein degradation pathways. Cu-binding proteins and transporters 
properly handle Cu cellular homeostasis and minimize its potential detrimental effects. High-
affinity Cu1+ import into eukaryotic cells is mediated by Ctr1/SLC31A1.  The extracellular 
oxidizing environment favors equilibrium toward Cu2+. Reduction of Cu2+ to Cu+ by plasma 
membrane metalloreductases (MR, encoded by the FRE1 and FRE2 genes in yeast 
(Georgatsou et al., 1997), or STEAP genes in humans (Ohgami et al., 2006)) is required to 
efficiently transport extracellular Cu across the plasma by Ctr1, which mediates the movement 
of Cu+ and not Cu2+ (Lee et al., 2002; Telianidis et al., 2013). On the other hand, P-type 
ATPase transporters ATP7AB, transport Cu+ or Cu2+ from the cytosol across cellular 
membranes, thus decreasing cytosolic Cu concentration. Intracellular Cu concentrations are 
tightly controlled by chelating systems for Cu, which include methalothioneins, chaperones 
(CCS), and GSH. In this work we demonstrated, that Cu can exert a synergistic toxic effect 
with either WT or A53T α-synuclein independent from α-synuclein aggregation. Cu toxicity was 
associated with the induction of apoptosis and was directly linked to intracellular GSH levels 
and modulation of Cu transport demonstrating the specific role of changes in intracellular Cu 
levels. This synergistic toxic effect of Cu and α-synuclein seems to be mediated by an 
increase “stress load” to protein degradation mechanisms, primarily the UPS, but to a lesser 
extent autophagy. This was revealed by the fact that impairment in proteasomal activity with 
MG132 stimulated the toxicity of CuCl2 and α-synuclein. In contrast, inhibition of Atg5-
dependent macroautophagy stimulated CuCl2-induced cell death, but did not affect cells 
overexpressing either form of α-synuclein.  Our findings do not discard a potential 
compensatory role of CMA, which is known to counteract the dysfunction in macroautophagy. 
In addition, we suggest that the toxic effect of Cu and α-synuclein might be associated with 
alterations in the native state of the monomer. 
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